Mendel key facts
as of Oct 2026- Developer of healthcare software designed to solve problems at each stage of the clinical trial process.
- Mendel is valued at approximately $118.0M as of Oct 2026 (last reported valuation).
- It has raised $113.9M; the latest was Later Stage VC ($35.0M) in Mar 2025.
- Notable investors include Plug and Play Tech Center, Y Combinator, Alumni Ventures, SOSV, Endeavor Catalyst — 37 tracked in total.
- Status: Privately Held (backing).
Mendel's last reported valuation, Mar 2022. Nothing priced has surfaced since.
- ·The complete investor list: 37 names
- ·Watch Mendel: the Monday email on marks, rounds and moves
Mendel funding rounds
No funding rounds for Mendel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Mendel
37+Membership and data by Private Market View
Mendel valuation
Mendel's last reported valuation was $118 million in Mar 2022. No priced round, secondary trade or fund mark has surfaced since.
Mendel investors
37 investors are on record for Mendel, including Plug and Play Tech Center, Y Combinator, Alumni Ventures and SOSV. By type, the record holds 10 venture capital firms and 1 angel investor.
About Mendel
Developer of healthcare software designed to solve problems at each stage of the clinical trial process. The company's software combines machine precision and human intuition from feasibility to post-trial pharmacovigilance, as well as transforms unstructured data and clinical literature into comprehensive and analytics-ready data, enabling clinical experts to streamline global oncology research by automating clinical trials.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2016
- Employees
- 96
- Website
- mendel.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.